Document is current

Article History

Received: 14 February 2023

Revised: 18 May 2023

Accepted: 25 May 2023

First Online: 3 June 2023

Declarations

:

: The authors declare no competing interests.

: The work done here does not involve any clinical interventions. Informed consent was not obtained as the stool sample of only one infant was used for isolation of probiotic strains. The sample is not stored and no further analysis has been conducted.

: Tata Chemicals Ltd is the manufacturer of prebiotics (Fossence). The work done in this article is not linked to this product. The authors declare no conflict of interest.